{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:42:30Z","timestamp":1792460550269,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12016-021-08880-3","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:03:30Z","timestamp":1627902210000},"page":"324-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":256,"title":["Update on the Pathogenesis and Therapy of Atopic Dermatitis"],"prefix":"10.1007","volume":"61","author":[{"given":"Huaguo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0785-8985","authenticated-orcid":false,"given":"Zhirong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"issue":"5","key":"8880_CR1","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","volume":"143","author":"A Ascott","year":"2019","unstructured":"Ascott A, Mulick A, Yu AM et al (2019) Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies. J Allergy Clin Immunol 143(5):1821\u20131829","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8880_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","volume":"137","author":"AM Drucker","year":"2017","unstructured":"Drucker AM, Wang AR, Li WQ et al (2017) The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol 137(1):26\u201330","journal-title":"J Invest Dermatol"},{"issue":"10247","key":"8880_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345\u2013360","journal-title":"Lancet"},{"issue":"2","key":"8880_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.anai.2019.05.014","volume":"123","author":"C McKenzie","year":"2019","unstructured":"McKenzie C, Silverberg JI (2019) The prevalence and persistence of atopic dermatitis in urban United States children. Ann Allergy Asthma Immunol 123(2):173-178.e1","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"8880_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.alit.2016.12.003","volume":"66","author":"I Katayama","year":"2017","unstructured":"Katayama I, Aihara M, Ohya Y et al (2017) Japanese guidelines for atopic dermatitis. Allergol Int 66(2):230\u2013247","journal-title":"Allergol Int"},{"key":"8880_CR6","doi-asserted-by":"crossref","first-page":"29751","DOI":"10.1038\/srep29751","volume":"6","author":"Y Guo","year":"2016","unstructured":"Guo Y, Li P, Tang J et al (2016) Prevalence of atopic dermatitis in Chinese children aged 1\u20137 ys. Sci Rep 6:29751","journal-title":"Sci Rep"},{"issue":"4","key":"8880_CR7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer CN, Irvine AD, Terron-Kwiatkowski A et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441\u2013446","journal-title":"Nat Genet"},{"issue":"1","key":"8880_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajhg.2014.12.004","volume":"96","author":"H Baurecht","year":"2015","unstructured":"Baurecht H, Hotze M, Brand S et al (2015) Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. Am J Hum Genet 96(1):104\u2013120","journal-title":"Am J Hum Genet"},{"issue":"4","key":"8880_CR9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2340\/00015555-2578","volume":"97","author":"TM Luukkonen","year":"2017","unstructured":"Luukkonen TM, Kiiski V, Ahola M et al (2017) The value of FLG null mutations in predicting treatment response in atopic dermatitis: an observational study in Finnish patients. Acta Derm Venereol 97(4):456\u2013463","journal-title":"Acta Derm Venereol"},{"key":"8880_CR10","doi-asserted-by":"crossref","unstructured":"Margolis DJ, Mitra N, Wubbenhorst B et al (2019) Association of filaggrin loss-of-function variants with race in children with atopic dermatitis. JAMA Dermatol 31;155(11):1269\u20131276.","DOI":"10.1001\/jamadermatol.2019.1946"},{"issue":"3","key":"8880_CR11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1398-9995.2010.02493.x","volume":"66","author":"H Zhang","year":"2011","unstructured":"Zhang H, Guo Y, Wang W et al (2011) Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis. Allergy 66(3):420\u2013427","journal-title":"Allergy"},{"issue":"2","key":"8880_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1468-3083.2011.04435.x","volume":"27","author":"M Li","year":"2013","unstructured":"Li M, Liu Q, Liu J et al (2013) Mutations analysis in filaggrin gene in northern China patients with atopic dermatitis. J Eur Acad Dermatol Venereol 27(2):169\u2013174","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"8880_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.12.646","volume":"119","author":"T Nomura","year":"2007","unstructured":"Nomura T, Sandilands A, Akiyama M et al (2007) Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 119(2):434\u2013440","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8880_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3349\/ymj.2017.58.2.395","volume":"58","author":"HR On","year":"2017","unstructured":"On HR, Lee SE, Kim SE et al (2017) Filaggrin mutation in Korean patients with atopic dermatitis. Yonsei Med J 58(2):395\u2013400","journal-title":"Yonsei Med J"},{"issue":"14","key":"8880_CR15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","volume":"365","author":"AD Irvine","year":"2011","unstructured":"Irvine AD, McLean WH, Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365(14):1315\u20131327","journal-title":"N Engl J Med"},{"issue":"1","key":"8880_CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.anai.2014.10.019","volume":"114","author":"IJ Wang","year":"2015","unstructured":"Wang IJ, Lin TJ (2015) FLG P478S polymorphisms and environmental risk factors for the atopic march in Taiwanese children: a prospective cohort study. Ann Allergy Asthma Immunol 114(1):52\u201357","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"8880_CR17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaci.2019.05.024","volume":"144","author":"MS Elias","year":"2019","unstructured":"Elias MS, Wright SC, Remenyi J et al (2019) EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis. J Allergy Clin Immunol 144(2):470\u2013481","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8880_CR18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jaci.2019.10.030","volume":"145","author":"S Mucha","year":"2020","unstructured":"Mucha S, Baurecht H, Novak N et al (2020) Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression. J Allergy Clin Immunol 145(4):1208\u20131218","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8880_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2018.09.002","volume":"143","author":"A Peled","year":"2019","unstructured":"Peled A, Sarig O, Sun G et al (2019) Loss-of-function mutations in caspase recruitment domain-containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitis. J Allergy Clin Immunol 143(1):173\u2013181","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8880_CR20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","volume":"127","author":"A De Benedetto","year":"2011","unstructured":"De Benedetto A, Rafaels NM, McGirt LY et al (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127(3):773\u2013786","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"8880_CR21","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/jid.2013.19","volume":"133","author":"JI Silverberg","year":"2013","unstructured":"Silverberg JI, Hanifin J, Simpson EL (2013) Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol 133(7):1752\u20131759","journal-title":"J Invest Dermatol"},{"issue":"3","key":"8880_CR22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jid.2016.09.034","volume":"137","author":"S Blunder","year":"2017","unstructured":"Blunder S, R\u00fchl R, Moosbrugger-Martinz V et al (2017) Alterations in epidermal eicosanoid metabolism contribute to inflammation and impaired late differentiation in FLG-mutated atopic dermatitis. J Invest Dermatol 137(3):706\u2013715","journal-title":"J Invest Dermatol"},{"issue":"1","key":"8880_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2017.05.005","volume":"88","author":"M Danso","year":"2017","unstructured":"Danso M, Boiten W, van Drongelen V et al (2017) Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition. J Dermatol Sci 88(1):57\u201366","journal-title":"J Dermatol Sci"},{"issue":"3","key":"8880_CR24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12016-016-8548-5","volume":"51","author":"PY Ong","year":"2016","unstructured":"Ong PY, Leung DY (2016) Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol 51(3):329\u2013337","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"8880_CR25","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jid.2018.01.022","volume":"138","author":"B Shi","year":"2018","unstructured":"Shi B, Leung DY, Taylor PA et al (2018) Methicillin-resistant Staphylococcus aureus colonization is associated with decreased skin commensal bacteria in atopic dermatitis. J Invest Dermatol 138(7):1668\u20131671","journal-title":"J Invest Dermatol"},{"issue":"4","key":"8880_CR26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1172\/JCI124608","volume":"129","author":"E Goleva","year":"2019","unstructured":"Goleva E, Berdyshev E, Leung DY (2019) Epithelial barrier repair and prevention of allergy. J Clin Invest 129(4):1463\u20131474","journal-title":"J Clin Invest"},{"issue":"3","key":"8880_CR27","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/all.13622","volume":"74","author":"M Moriwaki","year":"2019","unstructured":"Moriwaki M, Iwamoto K, Niitsu Y et al (2019) Staphylococcus aureus from atopic dermatitis skin accumulates in the lysosomes of keratinocytes with induction of IL-1\u03b1 secretion via TLR9. Allergy 74(3):560\u2013571","journal-title":"Allergy"},{"key":"8880_CR28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaci.2016.07.029","volume":"139","author":"EA Kennedy","year":"2017","unstructured":"Kennedy EA, Connolly J, Hourihane JO et al (2017) Skin microbiome before development of atopic dermatitis: early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol 139:166\u2013172","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8880_CR29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2015.08.021","volume":"137","author":"H Song","year":"2016","unstructured":"Song H, Yoo Y, Hwang J et al (2016) Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol 137(3):852\u2013860","journal-title":"J Allergy Clin Immunol"},{"key":"8880_CR30","doi-asserted-by":"crossref","unstructured":"Chng KR, Tay AS, Li C et al (2016) Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat Microbiol 11;1(9):16106.","DOI":"10.1038\/nmicrobiol.2016.106"},{"issue":"1","key":"8880_CR31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/ced.14380","volume":"46","author":"XQ Hu","year":"2021","unstructured":"Hu XQ, Tang Y, Ju Y et al (2021) Scratching damages tight junctions through the Akt-claudin 1 axis in atopic dermatitis. Clin Exp Dermatol 46(1):74\u201381","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"8880_CR32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.16934","volume":"180","author":"T Tsakok","year":"2019","unstructured":"Tsakok T, Woolf R, Smith CH et al (2019) Atopic dermatitis: the skin barrier and beyond. Br J Dermatol 180(3):464\u2013474","journal-title":"Br J Dermatol"},{"issue":"6","key":"8880_CR33","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/bjd.15078","volume":"176","author":"M Orciani","year":"2017","unstructured":"Orciani M, Campanati A, Caffarini M et al (2017) T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem. Br J Dermatol 176(6):1569\u20131576","journal-title":"Br J Dermatol"},{"issue":"6","key":"8880_CR34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/jdv.12753","volume":"29","author":"DI Batista","year":"2015","unstructured":"Batista DI, Perez L, Orfali RL et al (2015) Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1\/Th2\/Th17 cytokines in adults with atopic dermatitis. J Eur Acad Dermatol Venereol 29(6):1091\u20131095","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"8880_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2014.07.010","volume":"76","author":"T Nomura","year":"2014","unstructured":"Nomura T, Kabashima K, Miyachi Y (2014) The panoply of \u03b1\u03b2T cells in the skin. J Dermatol Sci 76(1):3\u20139","journal-title":"J Dermatol Sci"},{"issue":"12","key":"8880_CR36","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/all.13223","volume":"72","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Emerson RO, Tipton C et al (2017) Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues. Allergy 72(12):2017\u20132025","journal-title":"Allergy"},{"key":"8880_CR37","doi-asserted-by":"crossref","unstructured":"Mack MR, Brestoff JR, Berrien-Elliott MM et al (2020) Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Sci Transl Med. 2020 26;12(532):eaay1005.","DOI":"10.1126\/scitranslmed.aay1005"},{"key":"8880_CR38","unstructured":"M\u00f6bus L, Rodriguez E, Harder I, et al (2020) Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis. J Allergy Clin Immunol Dec 31: S0091\u20136749(20)31640\u20137."},{"issue":"1","key":"8880_CR39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/all.14010","volume":"75","author":"KIM Looman","year":"2020","unstructured":"Looman KIM, van Meel ER, Grosserichter-Wagener C et al (2020) Associations of Th2, Th17, Treg cells, and IgA+ memory B cells with atopic disease in children: The Generation R Study. Allergy 75(1):178\u2013187","journal-title":"Allergy"},{"issue":"1","key":"8880_CR40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2019.01.015","volume":"144","author":"L Zhou","year":"2019","unstructured":"Zhou L, Leonard A, Pavel AB et al (2019) Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol 144(1):144\u2013156","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"8880_CR41","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/jdv.16346","volume":"34","author":"S Wang","year":"2020","unstructured":"Wang S, Zhu R, Gu C et al (2020) Distinct clinical features and serum cytokine pattern of elderly atopic dermatitis in China. J Eur Acad Dermatol Venereol 34(10):2346\u20132352","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"8880_CR42","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","volume":"136","author":"S Noda","year":"2015","unstructured":"Noda S, Su\u00e1rez-Fari\u00f1as M, Ungar B et al (2015) The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol 136(5):1254\u20131264","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8880_CR43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaci.2018.02.047","volume":"142","author":"HC Wen","year":"2018","unstructured":"Wen HC, Czarnowicki T, Noda S et al (2018) Serum from Asian patients with atopic dermatitis is characterized by TH2\/TH22 activation, which is highly correlated with nonlesional skin measures. J Allergy Clin Immunol 142(1):324\u2013328","journal-title":"J Allergy Clin Immunol"},{"key":"8880_CR44","doi-asserted-by":"crossref","unstructured":"Andersen L, Nyeland ME, Nyberg F (2020) Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A. Br J Dermatol 182(5):1176\u20131183.","DOI":"10.1111\/bjd.18451"},{"issue":"6","key":"8880_CR45","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","volume":"138","author":"LA Nattkemper","year":"2018","unstructured":"Nattkemper LA, Tey HL, Valdes-Rodriguez R et al (2018) The genetics of chronic itch: gene expression in the skin of atopic dermatitis and psoriasis patients with severe itch. J Invest Dermatol 138(6):1311\u20131317","journal-title":"J Invest Dermatol"},{"issue":"3","key":"8880_CR46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-015-8488-5","volume":"51","author":"NK Mollanazar","year":"2016","unstructured":"Mollanazar NK, Smith PK, Yosipovitch G (2016) Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol 51(3):263\u2013292","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"8880_CR47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cell.2020.12.035","volume":"184","author":"SS Mali","year":"2021","unstructured":"Mali SS, Bautista DM (2021) Basophils add fuel to the flame of eczema itch. Cell 184(2):294\u2013296","journal-title":"Cell"},{"issue":"1","key":"8880_CR48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40257-017-0299-4","volume":"19","author":"PP Vakharia","year":"2018","unstructured":"Vakharia PP, Chopra R, Silverberg JI (2018) Systematic review of diagnostic criteria used in atopic dermatitis randomized controlled trials. Am J Clin Dermatol 19(1):15\u201322","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"8880_CR49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.aller.2019.07.008","volume":"48","author":"A Akan","year":"2020","unstructured":"Akan A, Dibek-M\u0131s\u0131rl\u0131o\u011flu E, Civelek E et al (2020) Diagnosis of atopic dermatitis in children: comparison of the Hanifin-Rajka and the United Kingdom Working Party criteria. Allergol Immunopathol (Madr) 48(2):175\u2013181","journal-title":"Allergol Immunopathol (Madr)"},{"key":"8880_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19831","author":"KMA Endre","year":"2021","unstructured":"Endre KMA, Landr\u00f8 L, LeBlanc M et al (2021) Diagnosing atopic dermatitis in infancy using established diagnostic criteria: a cohort study. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.19831","journal-title":"Br J Dermatol"},{"issue":"9","key":"8880_CR51","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/all.13149","volume":"72","author":"R Cheng","year":"2017","unstructured":"Cheng R, Guo Y, Huang L et al (2017) Current status in diagnosis of atopic dermatitis in China. Allergy 72(9):1277\u20131278","journal-title":"Allergy"},{"issue":"7","key":"8880_CR52","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4103\/0366-6999.178960","volume":"129","author":"P Liu","year":"2016","unstructured":"Liu P, Zhao Y, Mu ZL et al (2016) Clinical features of adult\/adolescent atopic dermatitis and Chinese criteria for atopic dermatitis. Chin Med J (Engl) 129(7):757\u2013762","journal-title":"Chin Med J (Engl)"},{"key":"8880_CR53","doi-asserted-by":"crossref","unstructured":"Cheng R, Zhang H, Zong W et al (2020) Development and validation of new diagnostic criteria for atopic dermatitis in children of China. J Eur Acad Dermatol Venereo l34(3):542\u2013548.","DOI":"10.1111\/jdv.15979"},{"issue":"8","key":"8880_CR54","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jdv.15618","volume":"33","author":"Y Guo","year":"2019","unstructured":"Guo Y, Zhang H, Liu Q et al (2019) Phenotypic analysis of atopic dermatitis in children aged 1\u201312 months: elaboration of novel diagnostic criteria for infants in China and estimation of prevalence. J Eur Acad Dermatol Venereol 33(8):1569\u20131576","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"8880_CR55","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/jan.13551","volume":"74","author":"HK Son","year":"2018","unstructured":"Son HK, Kim DH, Lee H et al (2018) Family management of childhood atopic dermatitis. J Adv Nurs 74(6):1371\u20131379","journal-title":"J Adv Nurs"},{"issue":"6","key":"8880_CR56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/1942602X19856873","volume":"34","author":"S Schoessler","year":"2019","unstructured":"Schoessler S (2019) Atopic dermatitis: management in the school setting. NASN Sch Nurse 34(6):324\u2013328","journal-title":"NASN Sch Nurse"},{"issue":"4","key":"8880_CR57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/ACI.0000000000000376","volume":"17","author":"B Cabanillas","year":"2017","unstructured":"Cabanillas B, Brehler AC, Novak N (2017) Atopic dermatitis phenotypes and the need for personalized medicine. Curr Opin Allergy Clin Immunol 17(4):309\u2013315","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"8880_CR58","doi-asserted-by":"crossref","unstructured":"Wollenberg A, Barbarot S, Bieber T et al (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.J Eur Acad Dermatol Venereol 32(6): 850\u2013878.","DOI":"10.1111\/jdv.14888"},{"issue":"1","key":"8880_CR59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/all.13946","volume":"75","author":"N Stefanovic","year":"2020","unstructured":"Stefanovic N, Flohr C, Irvine AD (2020) The exposome in atopic dermatitis. Allergy 75(1):63\u201374","journal-title":"Allergy"},{"issue":"2","key":"8880_CR60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jdv.13301","volume":"30","author":"KA Engebretsen","year":"2016","unstructured":"Engebretsen KA, Johansen JD, Kezic S (2016) The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol 30(2):223\u2013249","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"8880_CR61","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","volume":"32","author":"A Wollenberg","year":"2018","unstructured":"Wollenberg A, Barbarot S, Bieber T et al (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 32(5):657\u2013682","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8880_CR62","doi-asserted-by":"crossref","unstructured":"Wollenberg A, Christen-Z\u00e4ch S, Taieb A (2020) European task force on atopic dermatitis, EADV eczema task force. ETFAD, EADV Eczema task force, et al 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children J Eur Acad Dermatol Venereol. 34(12):2717-2744","DOI":"10.1111\/jdv.16892"},{"issue":"10228","key":"8880_CR63","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(19)32983-6","volume":"395","author":"HO Skjerven","year":"2020","unstructured":"Skjerven HO, Rehbinder EM, Vettukattil R et al (2020) Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. Lancet 395(10228):951\u2013961","journal-title":"Lancet"},{"issue":"4","key":"8880_CR64","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jaci.2017.09.034","volume":"141","author":"G du Toit","year":"2018","unstructured":"du Toit G, Sayre PH, Roberts G et al (2018) Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol 141(4):1343\u20131353","journal-title":"J Allergy Clin Immunol"},{"key":"8880_CR65","doi-asserted-by":"publisher","unstructured":"Hua T, Yousaf M, Gwillim E, et al (2020) Does daily bathing or showering worsen atopic dermatitis severity? A systematic review and meta-analysis. Arch Dermatol Res https:\/\/doi.org\/10.1007\/s00403-020-02164-0.","DOI":"10.1007\/s00403-020-02164-0"},{"issue":"4","key":"8880_CR66","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/pde.13842","volume":"36","author":"S Majewski","year":"2019","unstructured":"Majewski S, Bhattacharya T, Asztalos M et al (2019) Sodium hypochlorite body wash in the management of Staphylococcus aureus-colonized moderate-to-severe atopic dermatitis in infants, children, and adolescents. Pediatr Dermatol 36(4):442\u2013447","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"8880_CR67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.14483","volume":"175","author":"VY Shi","year":"2016","unstructured":"Shi VY, Foolad N, Ornelas JN et al (2016) Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split-body randomized controlled trial. Br J Dermatol 175(1):212\u2013214","journal-title":"Br J Dermatol"},{"issue":"4","key":"8880_CR68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2003.07.001","volume":"112","author":"A Wollenberg","year":"2003","unstructured":"Wollenberg A, Wetzel S, Burgdorf WH et al (2003) Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 112(4):667\u2013674","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8880_CR69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbalip.2013.10.002","volume":"1841","author":"J van Smeden","year":"2014","unstructured":"van Smeden J, Boiten WA, Hankemeier T et al (2014) Combined LC\/MS-platform for analysis of all major stratum corneum lipids, and the profiling of skin substitutes. Biochim Biophys Acta 1841(1):70\u201379","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"8880_CR70","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.jid.2020.01.014","volume":"140","author":"K Ishida","year":"2020","unstructured":"Ishida K, Takahashi A, Bito K et al (2020) Treatment with synthetic pseudoceramide improves atopic skin, switching the ceramide profile to a healthy skin phenotype. J Invest Dermatol 140(9):1762-1770.e8","journal-title":"J Invest Dermatol"},{"issue":"11","key":"8880_CR71","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/jdv.15786","volume":"33","author":"D McClanahan","year":"2019","unstructured":"McClanahan D, Wong A, Kezic S et al (2019) A randomized controlled trial of an emollient with ceramide and filaggrin-associated amino acids for the primary prevention of atopic dermatitis in high-risk infants. J Eur Acad Dermatol Venereol 33(11):2087\u20132094","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10228","key":"8880_CR72","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(19)32984-8","volume":"395","author":"JR Chalmers","year":"2020","unstructured":"Chalmers JR, Haines RH, Bradshaw LE et al (2020) Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Lancet 395(10228):962\u2013972","journal-title":"Lancet"},{"issue":"3","key":"8880_CR73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12016-015-8486-7","volume":"51","author":"M Chong","year":"2016","unstructured":"Chong M, Fonacier L (2016) Treatment of eczema: corticosteroids and beyond. Clin Rev Allergy Immunol 51(3):249\u2013262","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"8880_CR74","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","volume":"82","author":"AB Pavel","year":"2020","unstructured":"Pavel AB, Zhou L, Diaz A et al (2020) The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. J Am Acad Dermatol 82(3):690\u2013699","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8880_CR75","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaip.2014.04.009","volume":"2","author":"NH Nicol","year":"2014","unstructured":"Nicol NH, Boguniewicz M, Strand M et al (2014) Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program. J Allergy Clin Immunol Pract 2(4):400\u2013406","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4 Pt 1","key":"8880_CR76","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1542\/peds.105.4.794","volume":"105","author":"JA Ellison","year":"2000","unstructured":"Ellison JA, Patel L, Ray DW et al (2000) Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 105(4 Pt 1):794\u2013799","journal-title":"Pediatrics"},{"issue":"2","key":"8880_CR77","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaad.2016.02.1228","volume":"75","author":"JA Broeders","year":"2016","unstructured":"Broeders JA, Ahmed Ali U, Fischer G (2016) Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: a 15-year experience. J Am Acad Dermatol 75(2):410\u2013419","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"8880_CR78","first-page":"834","volume":"96","author":"M Deleuran","year":"2016","unstructured":"Deleuran M, Vestergaard C, V\u00f8lund A et al (2016) Topical calcineurin inhibitors, topical glucocorticoids and cancer in children: a nationwide study. Acta Derm Venereol 96(6):834\u2013835","journal-title":"Acta Derm Venereol"},{"key":"8880_CR79","doi-asserted-by":"crossref","unstructured":"Kempers S, Boguniewicz M, Carter E et al (2004) A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. J Am Acad Dermatol 51(4):515\u2013525.","DOI":"10.1016\/j.jaad.2004.01.051"},{"issue":"4","key":"8880_CR80","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1542\/peds.2014-1990","volume":"135","author":"B Sigurgeirsson","year":"2015","unstructured":"Sigurgeirsson B, Boznanski A, Todd G et al (2015) Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics 135(4):597\u2013606","journal-title":"Pediatrics"},{"issue":"4","key":"8880_CR81","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1367-5931(99)80068-4","volume":"3","author":"AM Doherty","year":"1999","unstructured":"Doherty AM (1999) Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Curr Opin Chem Biol 3(4):466\u2013473","journal-title":"Curr Opin Chem Biol"},{"issue":"5","key":"8880_CR82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamadermatol.2019.0008","volume":"155","author":"H Yang","year":"2019","unstructured":"Yang H, Wang J, Zhang X et al (2019) Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol 155(5):585\u2013593","journal-title":"JAMA Dermatol"},{"issue":"3","key":"8880_CR83","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS, Tom WL, Lebwohl MG et al (2016) Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol 75(3):494-503.e6","journal-title":"J Am Acad Dermatol"},{"key":"8880_CR84","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jaad.2017.06.010","volume":"77","author":"LF Eichenfield","year":"2017","unstructured":"Eichenfield LF, Call RS, Forsha DW et al (2017) Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis. J Am Acad Dermatol 77:641\u2013649","journal-title":"J Am Acad Dermatol"},{"key":"8880_CR85","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bjd.16046","volume":"178","author":"A Ahmed","year":"2018","unstructured":"Ahmed A, Solman L, Williams HC et al (2018) Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal. Br J Dermatol 178:659\u2013662","journal-title":"Br J Dermatol"},{"key":"8880_CR86","doi-asserted-by":"crossref","unstructured":"Bao L, Zhang H, Chan LS (2013) The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. JAKSTAT 2(3):e24137.","DOI":"10.4161\/jkst.24137"},{"key":"8880_CR87","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaad.2019.12.015","volume":"82","author":"H Nakagawa","year":"2020","unstructured":"Nakagawa H, Nemoto O, Igarashi A et al (2020) Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study. J Am Acad Dermatol 82:823\u2013831","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8880_CR88","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaci.2019.08.042","volume":"145","author":"BS Kim","year":"2020","unstructured":"Kim BS, Howell MD, Sun K et al (2020) Treatment of atopic dermatitis with ruxolitinib cream (JAK1\/JAK2 inhibitor) or triamcinolone cream. J Allergy Clin Immunol 145(2):572\u2013582","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8880_CR89","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjd.14871","volume":"175","author":"R Bissonnette","year":"2016","unstructured":"Bissonnette R, Papp KA, Poulin Y et al (2016) Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol 175(5):902\u2013911","journal-title":"Br J Dermatol"},{"key":"8880_CR90","doi-asserted-by":"crossref","unstructured":"Myles IA, Earland NJ, Anderson ED et al (2018) First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight 3(9):e120608.","DOI":"10.1172\/jci.insight.120608"},{"key":"8880_CR91","doi-asserted-by":"crossref","unstructured":"Myles IA, Castillo CR, Barbian KD et al (2020) Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair. Sci Transl Med 12(560):eaaz8631.","DOI":"10.1126\/scitranslmed.aaz8631"},{"issue":"5","key":"8880_CR92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.clindermatol.2016.05.011","volume":"34","author":"DL Rodenbeck","year":"2016","unstructured":"Rodenbeck DL, Silverberg JI, Silverberg NB (2016) Phototherapy for atopic dermatitis. Clin Dermatol 34(5):607\u2013613","journal-title":"Clin Dermatol"},{"key":"8880_CR93","doi-asserted-by":"crossref","unstructured":"Pacifico A, Iacovelli P, Damiani G et al (2019) \u2018High dose\u2019 vs. \u2018medium dose\u2019 UVA1 phototherapy in italian patients with severe atopic dermatitis. J Eur Acad Dermatol Venereol 33(4):718\u2013724.","DOI":"10.1111\/jdv.15362"},{"issue":"1","key":"8880_CR94","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2017.12.077","volume":"79","author":"A He","year":"2018","unstructured":"He A, Feldman SR, Fleischer AB Jr (2018) An assessment of the use of antihistamines in the management of atopic dermatitis. J Am Acad Dermatol 79(1):92\u201396","journal-title":"J Am Acad Dermatol"},{"key":"8880_CR95","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E et al (2016) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375:2335\u20132348","journal-title":"N Engl J Med"},{"issue":"5","key":"8880_CR96","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"M de Bruin-Weller","year":"2018","unstructured":"de Bruin-Weller M, Tha\u00e7i D, Smith CH et al (2018) Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAF\u00c9). Br J Dermatol 178(5):1083\u20131101","journal-title":"Br J Dermatol"},{"issue":"2","key":"8880_CR97","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamadermatol.2019.3617","volume":"156","author":"M Worm","year":"2020","unstructured":"Worm M, Simpson EL, Tha\u00e7i D et al (2020) Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: a randomized clinical trial. JAMA Dermatol 156(2):131\u2013143","journal-title":"JAMA Dermatol"},{"issue":"1","key":"8880_CR98","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","volume":"142","author":"JI Harper","year":"2000","unstructured":"Harper JI, Ahmed I, Barclay G et al (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142(1):52\u201358","journal-title":"Br J Dermatol"},{"issue":"2","key":"8880_CR99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/dth.12333","volume":"29","author":"JE Kim","year":"2016","unstructured":"Kim JE, Shin JM, Ko JY et al (2016) Importance of concomitant topical therapy in moderate-to-severe atopic dermatitis treated with cyclosporine. Dermatol Ther 29(2):120\u2013125","journal-title":"Dermatol Ther"},{"issue":"2","key":"8880_CR100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaip.2017.07.007","volume":"6","author":"C Goujon","year":"2018","unstructured":"Goujon C, Viguier M, Staumont-Sall\u00e9 D et al (2018) Methotrexate versus cyclosporine in adults with moderate-to-severe atopic dermatitis: a phase III randomized noninferiority trial. J Allergy Clin Immunol Pract 6(2):562\u2013569","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"8880_CR101","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/bjd.16240","volume":"178","author":"LAA Gerbens","year":"2018","unstructured":"Gerbens LAA, Hamann SAS, Brouwer MWD et al (2018) Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial. Br J Dermatol 178(6):1288\u20131296","journal-title":"Br J Dermatol"},{"issue":"6","key":"8880_CR102","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2010.04.027","volume":"64","author":"IM Haeck","year":"2011","unstructured":"Haeck IM, Knol MJ, Ten Berge O et al (2011) Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 64(6):1074\u20131084","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"8880_CR103","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/09546634.2019.1642996","volume":"31","author":"K Phan","year":"2020","unstructured":"Phan K, Smith SD (2020) Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis. J Dermatolog Treat 31(8):810\u2013814","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"8880_CR104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2500\/ar.2016.7.0164","volume":"7","author":"ME Breslin","year":"2016","unstructured":"Breslin ME, Lin JH, Roberts R et al (2016) Transient hypogammaglobulinemia and severe atopic dermatitis: open-label treatment with immunoglobulin in a case series. Allergy Rhinol (Providence) 7(2):69\u201373","journal-title":"Allergy Rhinol (Providence)"},{"issue":"3","key":"8880_CR105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12016-015-8499-2","volume":"51","author":"PH Wong","year":"2016","unstructured":"Wong PH, White KM (2016) Impact of immunoglobulin therapy in pediatric disease: a review of immune mechanisms. Clin Rev Allergy Immunol 51(3):303\u2013314","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"8880_CR106","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2015.07.039","volume":"137","author":"H Li","year":"2016","unstructured":"Li H, Li C, Zhang H et al (2016) Effects of lidocaine on regulatory T cells in atopic dermatitis. J Allergy Clin Immunol 137(2):613\u2013617","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8880_CR107","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2013.02.044","volume":"132","author":"JM Bae","year":"2013","unstructured":"Bae JM, Choi YY, Park CO et al (2013) Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 132(1):110\u2013117","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"8880_CR108","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/jdv.12813","volume":"29","author":"H Zhong","year":"2015","unstructured":"Zhong H, Deng X, Song Z et al (2015) Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite. J Eur Acad Dermatol Venereol 29(7):1318\u20131324","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"8880_CR109","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1172\/JCI70895","volume":"123","author":"TH Leung","year":"2013","unstructured":"Leung TH, Zhang LF, Wang J et al (2013) Topical hypochlorite ameliorates NF-\u03baB-mediated skin diseases in mice. J Clin Invest 123(12):5361\u20135370","journal-title":"J Clin Invest"},{"issue":"3","key":"8880_CR110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jaad.2014.04.045","volume":"71","author":"BH Kaffenberger","year":"2014","unstructured":"Kaffenberger BH, Mathis J, Zirwas MJ (2014) A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck predominant atopic dermatitis. J Am Acad Dermatol 71(3):480\u2013483","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8880_CR111","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jaci.2018.07.047","volume":"143","author":"T Werfel","year":"2019","unstructured":"Werfel T, Layton G, Yeadon M et al (2019) Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis. J Allergy Clin Immunol 143(5):1830\u20131837","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8880_CR112","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2019.06.031","volume":"144","author":"D Sakata","year":"2019","unstructured":"Sakata D, Uruno T, Matsubara K et al (2019) Selective role of neurokinin B in IL-31-induced itch response in mice. J Allergy Clin Immunol 144(4):1130-1133.e8","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8880_CR113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2332\/allergolint.13-OA-0672","volume":"63","author":"N Murakami-Satsutani","year":"2014","unstructured":"Murakami-Satsutani N, Ito T, Nakanishi T et al (2014) IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand. Allergol Int 63(3):443\u2013455","journal-title":"Allergol Int"},{"key":"8880_CR114","doi-asserted-by":"crossref","unstructured":"Kabashima K, Matsumura T, Komazaki H et al (2020) Nemolizumab-JP01 study group. trial of nemolizumab and topical agents for atopic dermatitis with pruritus. N Engl J Med 383(2):141\u2013150.","DOI":"10.1056\/NEJMoa1917006"},{"issue":"4","key":"8880_CR115","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","volume":"80","author":"EL Simpson","year":"2019","unstructured":"Simpson EL, Parnes JR, She D et al (2019) Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: a randomized phase 2a clinical trial. J Am Acad Dermatol 80(4):1013\u20131021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8880_CR116","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2018.11.053","volume":"144","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky E, Pavel AB, Zhou L et al (2019) GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol 144(2):482\u2013493","journal-title":"J Allergy Clin Immunol"},{"key":"8880_CR117","doi-asserted-by":"crossref","unstructured":"Chen YL, Gutowska-Owsiak D, Hardman CS et al (2019) Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Sci Transl Med 11(515):eaax2945.","DOI":"10.1126\/scitranslmed.aax2945"},{"issue":"4","key":"8880_CR118","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jaci.2016.07.001","volume":"138","author":"N Malhotra","year":"2016","unstructured":"Malhotra N, Yoon J, Leyva-Castillo JM et al (2016) IL-22 derived from \u03b3\u03b4 T cells restricts Staphylococcus aureus infection of mechanically injured skin. J Allergy Clin Immunol 138(4):1098-1107.e3","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8880_CR119","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaad.2018.01.016","volume":"78","author":"E Guttman-Yassky","year":"2018","unstructured":"Guttman-Yassky E, Brunner PM, Neumann AU et al (2018) Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial. J Am Acad Dermatol 78(5):872-881.e6","journal-title":"J Am Acad Dermatol"},{"key":"8880_CR120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaci.2018.06.016","volume":"142","author":"TC Chan","year":"2018","unstructured":"Chan TC, Sanyal RD, Pavel AB et al (2018) Atopic dermatitis in Chinese patients shows TH2\/TH17 skewing with psoriasiform features. J Allergy Clin Immunol 142:1013\u20131017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8880_CR121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/exd.13112","volume":"26","author":"S Khattri","year":"2017","unstructured":"Khattri S, Brunner PM, Garcet S et al (2017) Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis. Exp Dermatol 26(1):28\u201335","journal-title":"Exp Dermatol"},{"issue":"1","key":"8880_CR122","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaci.2007.11.016","volume":"121","author":"D Simon","year":"2008","unstructured":"Simon D, H\u00f6sli S, Kostylina G et al (2008) Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol 121(1):122\u2013128","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8880_CR123","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2008.03.007","volume":"121","author":"A Sediv\u00e1","year":"2008","unstructured":"Sediv\u00e1 A, Kayserov\u00e1 J, Vernerov\u00e1 E et al (2008) Anti-CD20 (rituximab) treatment for atopic eczema. J Allergy Clin Immunol 121(6):1515\u20131516","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8880_CR124","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000095299","volume":"141","author":"JM Oldhoff","year":"2006","unstructured":"Oldhoff JM, Darsow U, Werfel T et al (2006) No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients. Int Arch Allergy Immunol 141(3):290\u2013294","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"8880_CR125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","volume":"41","author":"FT Liu","year":"2011","unstructured":"Liu FT, Goodarzi H, Chen HY (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 41(3):298\u2013310","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"8880_CR126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000350486","volume":"162","author":"yengar SR, Hoyte EG, Loza A,","year":"2013","unstructured":"yengar SR, Hoyte EG, Loza A, et al (2013) Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial. Int Arch Allergy Immunol 162(1):89\u201393","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"8880_CR127","first-page":"990","volume":"8","author":"PM Heil","year":"2010","unstructured":"Heil PM, Maurer D, Klein B et al (2010) Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course-a randomized, placebo-controlled and double blind pilot study. J Dtsch Dermatol Ges 8(12):990\u2013998","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"8880_CR128","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jaci.2016.05.038","volume":"138","author":"HH Wang","year":"2016","unstructured":"Wang HH, Li YC, Huang YC (2016) Efficacy of omalizumab in patients with atopic dermatitis: a systematic review and meta-analysis. J Allergy Clin Immunol 138(6):1719\u20131722","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8880_CR129","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2019.11.025","volume":"145","author":"E Guttman-Yassky","year":"2020","unstructured":"Guttman-Yassky E, Tha\u00e7i D, Pangan AL et al (2020) Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial. J Allergy Clin Immunol 145(3):877\u2013884","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8880_CR130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjd.18898","volume":"183","author":"EL Simpson","year":"2020","unstructured":"Simpson EL, Lacour JP, Spelman L et al (2020) Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. Br J Dermatol 183(2):242\u2013255","journal-title":"Br J Dermatol"},{"issue":"4","key":"8880_CR131","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaad.2018.01.018","volume":"80","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky E, Silverberg JI, Nemoto O et al (2019) Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study. J Am Acad Dermatol 80(4):913-921.e9","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"8880_CR132","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamadermatol.2020.1406","volume":"156","author":"JI Silverberg","year":"2020","unstructured":"Silverberg JI, Simpson EL, Thyssen JP et al (2020) Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol 156(8):863\u2013873","journal-title":"JAMA Dermatol"},{"issue":"10246","key":"8880_CR133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(20)30732-7","volume":"396","author":"EL Simpson","year":"2020","unstructured":"Simpson EL, Sinclair R, Forman S et al (2020) Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet 396(10246):255\u2013266","journal-title":"Lancet"},{"issue":"4","key":"8880_CR134","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bjd.17932","volume":"181","author":"R Bissonnette","year":"2019","unstructured":"Bissonnette R, Maari C, Forman S et al (2019) The oral Janus kinase\/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study. Br J Dermatol 181(4):733\u2013742","journal-title":"Br J Dermatol"},{"issue":"5","key":"8880_CR135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bjd.17455","volume":"180","author":"YW Lee","year":"2019","unstructured":"Lee YW, Won CH, Jung K et al (2019) Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial. Br J Dermatol 180(5):1030\u20131038","journal-title":"Br J Dermatol"},{"issue":"1","key":"8880_CR136","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamadermatol.2017.3647","volume":"154","author":"V Navarro-L\u00f3pez","year":"2018","unstructured":"Navarro-L\u00f3pez V, Ram\u00edrez-Bosc\u00e1 A, Ram\u00f3n-Vidal D et al (2018) Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: a randomized clinical trial. JAMA Dermatol 154(1):37\u201343","journal-title":"JAMA Dermatol"},{"issue":"6","key":"8880_CR137","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/09546634.2015.1027168","volume":"26","author":"L Cao","year":"2015","unstructured":"Cao L, Wang L, Yang L et al (2015) Long-term effect of early-life supplementation with probiotics on preventing atopic dermatitis: a meta-analysis. J Dermatolog Treat 26(6):537\u2013540","journal-title":"J Dermatolog Treat"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08880-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08880-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08880-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:22:37Z","timestamp":1659079357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08880-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":137,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8880"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08880-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"21 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}